“…The most frequently reported MSCs markers were CD29, CD44, CD73, CD90, CD104, CD105, and CD106, while lacking expression of CD14, CD34, CD45, CD80, and HLA-DR. MSCs demonstrated differentiation potential into osteogenic, adipogenic, and chondrogenic lineages. Furthermore, some studies explored the use of induced pluripotent stem cells (iPSCs) [45], and human umbilical vein endothelial cells (HUVECs) [59,[61][62][63]67].…”